Terray Therapeutics, which uses AI to accelerate small-molecule drug development, raised a $120M Series B led by Bedford Ridge Capital and Nvidia's NVentures — Terray Therapeutics, a biotechnology company using artificial intelligence to accelerate the development of small-molecule drugs …
Posted from: this blog via Microsoft Power Automate.